Efficacy and Safety of Panitumumab Combined With Docetaxel and Cisplatin as a First-line Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Clinical trial NCT01379807 · UNKNOWN
Trial details
- NCT number
- NCT01379807
- Sponsor
- Grupo Gallego de Investigaciones Oncologicas
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2014-12-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.